methylphenidate stada hart hylki með breyttan losunarhraða 20 mg
stada arzneimittel ag - methylphenidatum hýdróklóríð; methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg
natriumklorid b. braun leysir fyrir stungulyf 9 mg/ml
b.braun melsungen ag* - natrii chloridum - leysir fyrir stungulyf - 9 mg/ml
kaliumklorid b. braun innrennslisþykkni, lausn 1 mmol/ml
b.braun melsungen ag* - kalii chloridum - innrennslisþykkni, lausn - 1 mmol/ml
methylphenidate stada hart hylki með breyttan losunarhraða 40 mg
stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 40 mg
methylphenidate stada hart hylki með breyttan losunarhraða 60 mg
stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 60 mg
ceprotin
takeda manufacturing austria ag - manna prótein c - purpura fulminans; protein c deficiency - blóðþurrðandi lyf - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
sterilt vann b. braun leysir fyrir stungulyf
b.braun melsungen ag* - aqua ad iniectabilia - leysir fyrir stungulyf
fosrenol tuggutafla 750 mg
takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 750 mg
fosrenol tuggutafla 500 mg
takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 500 mg
lomudal augndropar, lausn 20 mg/ml
stada arzneimittel ag - sodium cromoglicate - augndropar, lausn - 20 mg/ml